Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000227072 is annotated as *RAB22A, member RAS oncogene family pseudogene*. As a pseudogene, it does not encode a functional protein and is not considered a therapeutic target, nor does it have established biological functions or relevance to drug development. The true functional gene is RAB22A, a member of the small GTPase Rab family involved in membrane trafficking, but this specific ENSEMBL entry refers to a **pseudogene** (noncoding copy), not the protein-coding gene or functional protein[1][2][4]. As such, it should not be used as a molecular target for drugs, disease association, or biomarker discovery. Misidentification may occur if this pseudogene is confused with the coding RAB22A gene, which *is* functionally relevant in diseases like cancer; however, ENSG00000227072 itself is only the pseudogene, not the functional target[1][2][4]. **Note:** For data on cellular function, protein interactions, and disease roles, refer to the protein-coding *RAB22A* gene and its corresponding ENSEMBL ID, not to ENSG00000227072[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB22A, member RAS oncogene family pseudogene.